XML 24 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Non-controlling interest—Units in the operating partnership
Non-controlling interest—Members in Consolidated Entities
Beginning balance at Dec. 31, 2015 $ 3,729,037 $ 891 $ 1,710,979 $ (44,955) $ (1,081) $ 1,800,578 $ 262,625
Beginning balance (in shares) at Dec. 31, 2015   89,153,780          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Contributions 33,996           33,996
Distributions (1,303)           (1,303)
Proceeds from sale of common stock, net of underwriters’ discount and transaction costs 1,449,581 $ 470 1,449,111        
Proceeds from sale of common stock, net of underwriters' discount and transaction costs (in shares)   47,010,695          
Issuance of unrestricted stock 6 $ 6 0        
Issuance of unrestricted stock (in shares)   590,520          
Shares withheld to satisfy tax withholding (8,427) $ (3) (8,424)        
Shares withheld to satisfy tax withholding (in shares)   (262,760)          
Declared dividend (117,819)   (90,005)     (27,814)  
Amortization of stock-based compensation 14,654   13,609     1,045  
Net income (loss) 43,122     27,984   5,848 9,290
Change in fair value of derivatives 5,942       10,577 (4,635)  
Redemption of common units in the operating partnership (1,446,039)   34,124     (1,480,163)  
Ending balance at Dec. 31, 2016 3,702,750 $ 1,364 3,109,394 (16,971) 9,496 294,859 304,608
Ending balance (in shares) at Dec. 31, 2016   136,492,235          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Contributions 3,870           3,870
Distributions (74,836)           (74,836)
Proceeds from sale of common stock, net of underwriters’ discount and transaction costs 647,382 $ 187 647,195        
Proceeds from sale of common stock, net of underwriters' discount and transaction costs (in shares)   18,656,575          
Issuance of unrestricted stock 0 $ 9 (9)        
Issuance of unrestricted stock (in shares)   917,086          
Shares withheld to satisfy tax withholding (16,041) $ (4) (16,037)        
Shares withheld to satisfy tax withholding (in shares)   (463,388)          
Declared dividend (158,544)   (106,269) (51,619)   (656)  
Amortization of stock-based compensation 15,915   13,249     2,666  
Net income (loss) 93,925     68,590   375 24,960
Change in fair value of derivatives 7,398       7,353 45  
Redemption of common units in the operating partnership (310,855)   (24,535)   (3,622) (282,698)  
Ending balance at Dec. 31, 2017 $ 3,910,964 $ 1,556 3,622,988 0 13,227 14,591 258,602
Ending balance (in shares) at Dec. 31, 2017 155,602,508 155,602,508          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Transition Entry $ 0     (231) 230 1 0
Contributions 2,486           2,486
Distributions (4,725)           (4,725)
Issuance of unrestricted stock 0 $ 5 (5)        
Issuance of unrestricted stock (in shares)   571,481          
Shares withheld to satisfy tax withholding (4,753) $ (2) (4,751)        
Shares withheld to satisfy tax withholding (in shares)   (163,191)          
Repurchase of common stock $ (50,016) $ (16) (50,000)        
Repurchase of common stock (in shares) (1,639,260)            
Declared dividend $ (157,003)   (57,769) (98,522)   (712)  
Amortization of stock-based compensation 18,125   14,039     4,086  
Net income (loss) 110,994     98,753   358 11,883
Change in fair value of derivatives 4,058       4,044 14  
Ending balance at Dec. 31, 2018 $ 3,830,130 $ 1,543 $ 3,524,502 $ 0 $ 17,501 $ 18,338 $ 268,246
Ending balance (in shares) at Dec. 31, 2018 154,371,538 154,371,538